Gene Manipulation In Human Embryos Provokes Ethical Questions
By Rahel Gebreyes,
HuffPost Live
| 11. 17. 2015
[cites CGS' Marcy Darnovsky]
Untitled Document
A team of Chinese scientists raised eyebrows in April when they modified the genetic code of human embryos to correct the gene defect that causes the hereditary blood disease beta-thalassemia. Now, many researchers and ethicists fear that the technology used to make those manipulations might one day be "exploited for non-therapeutic modifications" such as selecting for intelligence and physical appearance.
While gene editing technology may offer serious health opportunities, it also poses ethical questions, especially if scientists use it for reasons other than preventing illness or diseases, according to Dr. Marcy Darnovsky, executive director of the Center for Genetics and Society.
"Using gene editing on human embryos for reproduction -- that's not really even a medical approach. That's not treating anybody who is sick. That's creating new human beings," Darnovsky told HuffPost Live's Josh Zepps in a video segment (above) on Monday.
As she explained, gene-modification skeptics have raised a number of objections to the budding technology. Darnovsky said:
"There are totally secular objections to it -- having to do with the safety, having to do with the fact...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...